当前位置:首页 - 行情中心 - 科兴制药(688136) - 财务分析 - 现金流量表

科兴制药

(688136)

  

流通市值:76.66亿  总市值:76.66亿
流通股本:2.00亿   总股本:2.00亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金304,402,163.861,146,887,816.23864,229,786.56566,581,536.26
收到的税费返还99,647.31498,482.6521,652.949,491.15
收到其他与经营活动有关的现金6,118,879.5752,289,583.6931,040,785.6824,378,430.14
经营活动现金流入的平衡项目0000
经营活动现金流入小计310,620,690.741,199,675,882.57895,292,225.18590,969,457.55
购买商品、接受劳务支付的现金68,088,184.9189,659,020.82138,844,276.92107,403,164.06
支付给职工以及为职工支付的现金52,258,457.22223,605,975.34172,341,672.82117,452,762.39
支付的各项税费20,088,985.7661,005,781.6950,118,861.0236,646,351.59
支付其他与经营活动有关的现金144,739,915.22618,735,368.31480,718,199.88363,496,337.71
经营活动现金流出的平衡项目0000
经营活动现金流出小计285,175,543.11,093,006,146.16842,023,010.64624,998,615.75
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额25,445,147.64106,669,736.4153,269,214.54-34,029,158.2
二、投资活动产生的现金流量:
收回投资收到的现金344,850,0001,947,494,135.361,483,000,000942,000,000
取得投资收益收到的现金4,032,679.489,895,037.615,857,251.854,048,665.77
处置固定资产、无形资产和其他长期资产收回的现金净额30,00038,12531,2253,310
收到的其他与投资活动有关的现金15,0001,891,2001,756,2001,676,200
投资活动现金流入的平衡项目0000
投资活动现金流入小计348,927,679.481,959,318,497.971,490,644,676.85947,728,175.77
购建固定资产、无形资产和其他长期资产支付的现金8,281,017.9393,991,409.6467,241,901.9150,905,761.9
投资支付的现金450,850,0001,955,862,3801,645,000,0001,016,000,000
支付其他与投资活动有关的现金133,00013,590,05013,320,0502,200,000
投资活动现金流出的平衡项目0000
投资活动现金流出小计459,264,017.932,063,443,839.641,725,561,951.911,069,105,761.9
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-110,336,338.45-104,125,341.67-234,917,275.06-121,377,586.13
三、筹资活动产生的现金流量:
吸收投资收到的现金-6,964,520--
取得借款收到的现金176,879,579.9627,655,263.9436,755,263.9311,354,263.9
筹资活动现金流入平衡项目0000
筹资活动现金流入小计176,879,579.9634,619,783.9436,755,263.9311,354,263.9
偿还债务支付的现金143,597,465.44559,465,826.85437,332,505.83218,535,034.47
分配股利、利润或偿付利息支付的现金10,289,110.1443,634,014.8833,494,795.6522,001,566.99
支付其他与筹资活动有关的现金2,328,679.9142,434,149.3640,412,983.7937,984,332.76
筹资活动现金流出平衡项目0000
筹资活动现金流出小计156,215,255.49645,533,991.09511,240,285.27278,520,934.22
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额20,664,324.41-10,914,207.19-74,485,021.3732,833,329.68
四、汇率变动对现金及现金等价物的影响449,313.931,391,169.29731,760.74971,110.16
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-63,777,552.47-6,978,643.16-255,401,321.15-121,602,304.49
加:期初现金及现金等价物余额553,198,403.29559,930,585.75559,930,585.75559,930,585.75
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额489,420,850.82552,951,942.59304,529,264.6438,328,281.26
补充资料:
净利润-27,048,555.4-9,461,466.66
资产减值准备-3,669,050.48-2,187,250.09
固定资产和投资性房地产折旧-67,067,060.21-32,303,447.35
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-67,067,060.21-32,303,447.35
无形资产摊销-20,806,116.93-9,375,517.79
长期待摊费用摊销-5,897,822.15-2,864,894.54
处置固定资产、无形资产和其他长期资产的损失--77,059.28--100,857.6
固定资产报废损失-172,386.94-92,849.9
公允价值变动损失-29,188,617.47-13,940,667.35
财务费用-43,357,485.96-20,872,267.75
投资损失--9,538,871.79--4,084,588.18
递延所得税-12,877,959.59-16,780,923.83
其中:递延所得税资产减少-16,758,057.1-17,578,066.75
递延所得税负债增加--3,880,097.51--797,142.92
存货的减少-45,886,448.54-33,308,468.57
经营性应收项目的减少--228,070,473.68--181,337,648.93
经营性应付项目的增加-69,458,817.36--3,546,429.93
其他-4,366,892.5-3,107,919.48
现金的期末余额-552,951,942.59-438,328,281.26
减:现金的期初余额-559,930,585.75-559,930,585.75
公告日期2025-04-282025-04-112024-10-262024-08-20
审计意见(境内)标准无保留意见
TOP↑